Irlanda - engleză - HPRA (Health Products Regulatory Authority)

e.c. de witt & company limited - paracetamol - syrup

Irlanda - engleză - HPRA (Health Products Regulatory Authority)

e.c. de witt & company limited - syrup

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - ondansetron (unii: 4af302esos) (ondansetron - unii:4af302esos) - ondansetron 4 mg - 1. prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin ≥ 50 mg/m2 . 2. prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy. 3. prevention of nausea and vomiting associated with radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen. 4. prevention of postoperative nausea and/or vomiting. as with other antiemetics, routine prophylaxis is not recommended for patients in whom there is little expectation that nausea and/or vomiting will occur postoperatively. in patients where nausea and/or vomiting must be avoided postoperatively, ondansetron hydrochloride tablets, ondansetron orally disintegrating tablets, and ondansetron hydrochloride oral solution are recommended even where the incidence of postoperative nausea and/or vomiting is low. the concomitant use of apomorphine with ondansetron is contraindic

Regatul Unit - engleză - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - pantoprazole sodium sesquihydrate - gastro-resistant tablet - 20mg

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

proficient rx lp - ondansetron (unii: 4af302esos) (ondansetron - unii:4af302esos) - 1. prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin ≥ 50 mg/m2 . 2. prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy. 3. prevention of nausea and vomiting associated with radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen. 4. prevention of postoperative nausea and/or vomiting. as with other antiemetics, routine prophylaxis is not recommended for patients in whom there is little expectation that nausea and/or vomiting will occur postoperatively. in patients where nausea and/or vomiting must be avoided postoperatively, ondansetron hydrochloride tablets, ondansetron orally disintegrating tablets, and ondansetron hydrochloride oral solution are recommended even where the incidence of postoperative nausea and/or vomiting is low. the concomitant use of apomorphine with ondansetron is contraindic

Kenya - engleză - Pharmacy and Poisons Board

ferring gmbh wittland kiel 11 24109 germany - desmopressin - tablet - 0.2mg 0.1mg - posterior pituitarylobe hormones: vasopressin and

Kenya - engleză - Pharmacy and Poisons Board

ferring gmbh wittland 11 24109 kiel germany - mesalazine - granules for oral solution in sachet - 2g - mesalazine

Australia - engleză - APVMA (Australian Pesticides and Veterinary Medicines Authority)

wellpet, llc - omega 3 fatty acid; omega 6 fatty acid; taurine; glucosamine hydrochloride; amylase; cellulase; protease; carotene-beta; carnitine - l; total bacillus organisms; total lactic acide producing organisms; moisture; crude fat; crude fibre; crude protein; calcium; phosphorus; vitamin a; vitamin c = ascorbic acid; vitamin e - oral food (can/semi-dry/dry) - omega 3 fatty acid acid-fatty active 0.5 %; omega 6 fatty acid acid-fatty active 2.8 %; taurine amino zwitterion active 0.11 %; glucosamine hydrochloride carbohydrate-glucose active 82.0 mg/cup; amylase enzyme active 5.0 dxu/lb; cellulase enzyme active 100.0 cu/lb; protease enzyme active 280.0 hut/lb; carotene-beta vitamin-a active 5.0 mg/kg; carnitine - l vitamin-bt active 150.0 mg/kg; total bacillus organisms biological-organism active 7.0 mcfu/lb; total lactic acide producing organisms biological organism active 240.0 mcfu/lb; moisture ungrouped other 10.0 %; crude fat dietary other 14.0 %; crude fibre dietary other 3.9 %; crude protein dietary other 24.0 %; calcium mineral-calcium other 1.0 %; phosphorus mineral-phosphorus other 0.8 %; vitamin a vitamin-a other 22000.0 iu/kg; vitamin c = ascorbic acid vitamin-c other 30.0 mg/kg; vitamin e vitamin-e other 165.0 iu/kg - nutrition & metabolism - dog - extra large | dog - large - prescription diet | dietary management of obesity, | early cardiac disease | food allergy | gastrointestinal disorders | hepatitus, kidney disease, | lower urinary tract support | pancreatitis, gastroenteritis | renal function | struvite urolithiasis

Armenia - engleză - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

glaxo wellcome s.a. - pazopanib - tablets film-coated - 400mg

Armenia - engleză - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

glaxo wellcome s.a. - pazopanib - tablets film-coated - 200mg